Drug pipeline
Explore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Endothelial heparan sulfate proteoglycans (HSPGs) are highly glycosylated proteins located on the luminal surface of vascular endothelial cells and within the basement membrane, serving as a major structural and functional component of the endothelial glycocalyx. They consist of a core protein (such as syndecans or glypicans) covalently linked to negatively charged heparan sulfate glycosaminoglycan chains. Endothelial HSPGs play critical roles in maintaining vascular homeostasis by regulating vascular permeability, microcirculatory tone, leukocyte adhesion, and coagulation. They also act as mechanosensors of fluid shear stress and serve as co-receptors or reservoirs for various growth factors, chemokines, and cytokines (such as FGF, VEGF, and IL-8). In pathological states like sepsis, inflammation, and cancer, endothelial HSPGs are shed from the cell surface through the action of sheddases and heparanase, leading to glycocalyx degradation, vascular leakage, and thrombosis. Therapeutic strategies targeting endothelial HSPGs include heparan sulfate mimetics, heparanase inhibitors, and low-molecular-weight heparins, which aim to preserve glycocalyx integrity, competitively block pathological ligand binding, or neutralize circulating inflammatory mediators.
Competitive inhibition of ligand binding to heparan sulfate chains, stabilization of endothelial glycocalyx, inhibition of heparanase-mediated degradation, or neutralization of circulating histones and inflammatory mediators.
8 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Endothelial heparan sulfate proteoglycans (Endothelial HSPGs).